Login Register
icon_bulk_orderBulk order Acrobiosystems for ChineseChinese
Recombinant Proteins ClearClear history
Recombinant Proteins CloseClose
Browse Products By Molecule Name a-zA-Z
SARS-CoV-2 | CD24 | CD73 | Trimer | CD19 | PD-1
0
There is no goods in the shopping cart !
My Cart
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > GUCY2C

GUCY2C

GUCY2C Molecule Information

Name:Heat-stable enterotoxin receptor
Target Synonym:EC 4.6.1?EC:4.6.1.2?GC-C?STAR?GUC2C?hSTAR?GUCY2C?Guanylate Cyclase 2C?STA Receptor?Guanylyl Cyclase C?Guanylate Cyclase 2C (Heat Stable Enterotoxin Receptor)?Heat-Stable Enterotoxin Receptor?Heat Stable Enterotoxin Receptor?EC 4.6.1.2?DIAR6?MECIL?MUCIL?In
Number of Launched Drugs:1
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Approved

GUCY2C Protein Product ListCompare or Buy

Product> Filter Results
By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
GUC-H82E9 Human Biotinylated Human GUCY2C / Guanylyl cyclase C Protein, His,Avitag™
GUC-H82E9-structure
GUC-H82E9-sds
GUC-H82E9-elisa_1
GUC-C5255 Cynomolgus Cynomolgus GUCY2C / Guanylyl cyclase C Protein, Fc Tag
GUC-C5255-structure
GUC-C5255-sds
GUC-C5255-elisa_1
GUC-C52H6 Cynomolgus Cynomolgus GUCY2C / Guanylyl cyclase C Protein, His Tag
GUC-C52H6-structure
GUC-C52H6-sds
GUC-C52H6-elisa_1
GUC-M5254 Mouse Mouse GUCY2C / Guanylyl cyclase C Protein, Fc Tag
GUC-M5254-structure
GUC-M5254-sds
GUC-M52H3 Mouse Mouse GUCY2C / Guanylyl cyclase C Protein, His Tag
GUC-M52H3-structure
GUC-M52H3-sds
GUC-H82F8 Human Biotinylated Human GUCY2C / Guanylyl cyclase C Protein, Fc,Avitag™
GUC-H82F8-structure
GUC-H82F8-sds
GUC-H82F8-elisa_1
GUC-HF2H8 Human FITC-Labeled Human GUCY2C / Guanylyl cyclase C Protein, His Tag
GUC-HF2H8-structure
GUC-HF2H8-sds
GUC-HF2H8-elisa_1
GUC-H52H5 Human Human GUCY2C / Guanylyl cyclase C Protein, His Tag
GUC-H52H5-structure
GUC-H52H5-sds
GUC-H52H5-elisa_1
GUC-H5257 Human Human GUCY2C / Guanylyl cyclase C Protein, Fc Tag
GUC-H5257-structure
GUC-H5257-sds
GUC-H5257-elisa_1

GUCY2C Part of Bioactivity data

GUC-HF2H8-Cell-based assay
FACS assay shows that recombinant Biotinylated FACS

2e5 of Anti-GUCY2C CAR-293 cells were stained with 100 μL of 1 μg/mL of FITC-Labeled Human GUCY2C, His Tag (Cat. No. GUC-HF2H8) and negative control protein respectively, FITC signal was used to evaluate the binding activity(QC tested).

Protocol
GUC-H52H5-Cell-based assay
FACS assay shows that recombinant Biotinylated FACS

2e5 of anti-GUCY2C CAR-293 cells were stained with 100 µL of 1 µg/mL Human GUCY2C, His Tag (Cat. No. GUC-H52H5) and negative control protein respectively, washed and then followed by PE anti-His antibody and analyzed with FACS (Routinely tested).

Protocol
GUC-C5255-ELISA
Cynomolgus GUCY2C, Fc TagCynomolgus GUCY2C, Fc Tag (Cat. No. GUC-C5255) ELISA bioactivity

Immobilized Cynomolgus GUCY2C, Fc Tag (Cat. No. GUC-C5255) at 1 μg/mL (100 μL/well) can bind Monoclonal Anti-Human GUCY2C Antibody, Human IgG1 (Cat. No. GUC-M78) with a linear range of 0.1-3 ng/mL (QC tested).

Protocol
GUC-H82E9-ELISA
Biotinylated Human GUCY2C, His,AvitagBiotinylated Human GUCY2C, His,Avitag (Cat. No. GUC-H82E9) ELISA bioactivity

Immobilized Biotinylated Human GUCY2C, His,Avitag (Cat. No. GUC-H82E9) at 1 μg/mL (100 μL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 μg/well) plate, can bind Monoclonal Anti-Human GUCY2C Antibody, Human IgG1 with a linear range of 0.2-2 ng/mL (QC tested).

Protocol

GUCY2C Molecule Synonym Name

GUCY2C,GUC2C,STAR,STA receptor,hSTAR,GC-C

GUCY2C Molecule Background

GUCY2C (Guanylyl Cyclase C), also known as heat-stable enterotoxin receptor, is a type I transmembrane protein of the guanylate cyclase (gc) family that signal by producing cGMP. Guanylate cyclase C (GUCY2C) and its hormones guanylin and uroguanylin have recently emerged as one paracrine axis defending intestinal mucosal integrity against mutational, chemical, and inflammatory injury. GUCY2C murine CAR-T cells recognized and killed human colorectal cancer cells endogenously expressing GUCY2C. Thus, we have identified a human GUCY2C-specific CAR-T cell therapy approach that may be developed for the treatment of GUCY2C-expressing metastatic colorectal cancer.

GUCY2C References

GUCY2C Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Plecanatide SP-304; GCRA Approved Synergy Pharmaceuticals Trulance United States Constipation; Chronic idiopathic constipation s:21:"Salix Pharmaceuticals"; 2017-01-19 Constipation; Irritable Bowel Syndrome; Chronic idiopathic constipation Details

GUCY2C Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Dolcanatide SP-333; WU-977T914K Phase 2 Clinical Synergy Pharmaceuticals Constipation Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America: +1 800-810-0816 (Toll Free)
Asia & Pacific: +86 400-682-2521
Email
Email
order@acrobiosystems.com
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA
linkedin twitter facebook

Subscribe newsletter

Leave a message

Copyright © 2017 ACROBiosystems. All Rights Reserved
中文网站|Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap